In recognition of World Environment Month, Genmab colleagues in Japan were proud to continue our longstanding partnership with Maggie’s Tokyo by helping beautify their garden for visitors to enjoy. Maggie’s Tokyo is a welcoming place where people living with cancer, as well as their families and friends, can connect with healthcare professionals and receive support. Through this volunteer activity, we aimed to help maintain a peaceful space for patients and their loved ones. This meaningful project reflects Genmab’s commitment to supporting environmental initiatives and patient communities and creating a positive impact in the communities where we live and work.
Welcome to Genmab’s June Edition of Knock-Your-Socks-Off-News, a monthly newsletter covering our current happenings across the globe. Follow along with us on our journey for more updates as we advance innovation and continue to work towards our goal of transforming the lives of patients through antibody medicines.
We’re pleased to announce that Margarida Duarte has joined Genmab as General Manager for Europe and Emerging Markets. This appointment marks an important step as we continue to strengthen our presence across the region and work to bring innovative antibody medicines to more patients. Welcome, Margarida, to Genmab! Read more here: http://gmab.ly/AXfe50YzjrE.
Learn how Genmab began with a bold idea to harness the power of antibodies to fight cancer and other serious diseases and how that vision is now making an impact for patients. From challenging the status quo to leveraging data-driven insights, this video highlights how we are advancing antibody medicines with patients at the center of every step. At Genmab, we don’t just focus on antibodies — we focus on the people behind every breakthrough.
Three Genmab colleagues were recently elected to our Board of Directors for a three-year term, continuing our long-standing tradition of employee representation. This ensures our team’s voice is part of decision-making and strengthens our culture of collaboration and innovation. Congratulations Martin Schultz, Mijke Zachariasse and Mike Kavanagh on being elected to our board of directors by Genmab colleagues!
ICYMI: We recently published our 2024 Annual Report. Executive Vice President and Chief Financial Officer Anthony Pagano shares how our strategic investments and focus on late-stage programs are driving our evolution into a biotech innovation powerhouse. Read the report: http://gmab.ly/uvbl50UYQ4c
#InvestorUpdate: We’ve published our Interim Report for the first nine months of 2024. Hear from Anthony Pagano, Executive Vice President & Chief Financial Officer on our progress toward our goal to impact patients’ lives with antibody medicines.
As an organization that aims to improve the lives of patients with innovative antibody medicines, we recognize the critical role that caregivers play in the patient journey, and we are proud to have an employee resource group, Community of Caregivers that aims to promote and sustain an inclusive culture where colleagues who serve as care partners for family members are encouraged to sustain work-life harmony. In recognition of Family Caregivers month, Cecilia (Tsang) Fong Director, Business Insights & Analytics and Co-Lead of Community of Caregivers, shares more about our efforts to support colleagues and her role in this initiative.
